Another finding was decreased tau expression in the entorhinal cortex of MTLE + D patients taking fluoxetine, in agreement with tau mRNA downregulation described in Parkinson's patients taking fluoxetine [71]. The gene discussed is MAPT; the disease is Parkinsonism.